Changsheng Bio (002680) announced on the evening of July 24 that the company's stock will be suspended for one day on July 25 and resume trading on the 26th. The company's stock has been implemented with other risk warnings since July 26, and the stock short name has been changed to “ST Changsheng”. The company's stock trading day is limited to 5%.
The company said that Changchun Changsheng has stopped the production and sales of rabies vaccine. All products of the subsidiary have been suspended from the batch. After research, the company decided to adopt a comprehensive and independent production stoppage for other products of the company, and carry out comprehensive and thorough rectification. The current time for resumption of production is uncertain. The company's production and operation activities have been seriously affected and it is expected that it will not return to normal within three months.
The following is the full text of the announcement:
According to the Changchun New District Public Security Bureau, on July 24, 15 persons involved in the case of Gao Changfang, chairman of Changchun Changsheng Biotechnology Co., Ltd., were suspected of criminal offences and were subject to criminal detention compulsory measures by the Changchun New District Public Security Bureau. The current work related to the case is underway.
Changsheng Biotechnology also announced on the afternoon of July 24, at 15 o'clock on the afternoon of July 23, Changchun New District Public Security Bureau of Changchun City, Changchun Changsheng production of freeze-dried human rabies vaccine suspected of criminal cases, the main suspects involved in the company chairman, 3 The company’s senior executives and two middle-level personnel were brought to the public security organs for review. At present, the company has set up an emergency response team and established a corresponding emergency mechanism. The company's production and operation activities have been seriously affected, and stocks may implement other risk warnings.
On July 23, according to Xinhua News Agency, Xi Jinping, general secretary of the CPC Central Committee, chairman of the State Council and chairman of the Central Military Commission, made important instructions on the Changchun Changsheng Biological Vaccine Case in Jilin Province, pointing out that Changchun Changsheng Biotechnology Co., Ltd. illegally produced vaccines. The nature is bad and shocking. Relevant localities and departments should attach great importance to it, immediately investigate the truth of the matter, check it in the end, be serious and accountable, and deal with it strictly according to law. It is necessary to promptly announce the progress of the investigation and effectively respond to the concerns of the people. Xi Jinping emphasized that ensuring drug safety is the unshirkable responsibility of party committees and governments at all levels. We must always put the physical health of the people in the first place, and take the determination to use drugs to cure phlegm and cure bones, improve China's vaccine management system, and resolutely defend safety. The bottom line is to fully protect the vital interests of the people and the overall security and social stability.
Li Keqiang, member of the Standing Committee of the Political Bureau of the CPC Central Committee and Premier of the State Council, issued an instruction request. The State Council immediately sent an investigation team to conduct a thorough investigation of the entire chain of all vaccine production and sales, and to find out the truth as soon as possible, regardless of which enterprises involved and who are determined. Strictly punish and not tolerate. We will resolutely crack down on all illegal and criminal acts that endanger the safety of people's lives, and resolutely punish those who violate the law according to law, and resolutely and severely criticize the behavior of dereliction of duty and dereliction of duty. As soon as possible, the people will have a safe, secure and trustworthy living environment.
According to the instructions of Xi Jinping and Li Keqiang, the State Council established a special working mechanism and sent an investigation team to Changchun Changsheng Biotechnology Co., Ltd. to conduct an investigation. The investigation team will promptly complete the investigation of the case, the investigation of the responsibility, and the investigation of the hidden dangers. Jilin Province established a provincial and municipal level investigation and handling leading group, cooperated with the investigation team of the State Council to do relevant work, and comprehensively investigated high-risk pharmaceutical companies in combination with this case. Jilin Food and Drug Administration has recovered the GMP certificate for Changchun Changsheng Rabies Vaccine Drugs, stopped the production and sales of the company's rabies vaccine, and suspended the issuance of all products of the company.
On July 23, Changsheng Biotechnology Co., Ltd. was investigated by the Securities and Futures Commission for alleged violations of information disclosure. On the same day, the company disclosed that if the company was finally found to have a major illegal act or transferred to the public security organ due to the above-mentioned investigation, the company's stock may be subject to delisting risk according to the relevant provisions of the Shenzhen Stock Exchange Listing Rules. Warning, suspension of listing or termination of listing.
The Shenzhen Stock Exchange stated that in order to ensure the relevant shareholders of the company to abide by the China Securities Regulatory Commission, "Several Provisions of Shareholders and Directors of Listed Companies, and Reduction of Shareholdings", "Shenzhen Stock Exchange Listed Company Shareholders and Directors, Supervisors and Senior Management According to the regulations, the Shenzhen Stock Exchange has restricted the sale of shares held by Changsheng Bio-large shareholder and Dong Jiangao.
In addition, according to the notification from the State Food and Drug Administration, the company has been ordered to stop production. The company disclosed that the freeze-dried human rabies vaccine and the Baibai broken combination vaccine have been discontinued. The Shenzhen Stock Exchange will pay close attention to the progress of related matters. If the company has serious impact on the production and operation activities as stipulated in Article 13.3.1 of the Shenzhen Stock Exchange Listing Rules, the Shenzhen Stock Exchange will implement other risk warnings on the company's stock trading.
In terms of stock price, Changsheng Biology fell for the seventh consecutive day today, at 11.75 yuan, and the market value has evaporated 12.4 billion yuan. According to the daily economic news report, the Oriental Fund announced that since July 23, 2018, the price of the "Changsheng Bio" stock held by its securities investment fund has been adjusted, according to its 2017 net asset value of 3.96 yuan per share. Valuation. Compared with the price of 11.75 yuan after the daily limit, it is equivalent to 3.4 fold, and it is equivalent to 10 down limit.